[Vasodilator agents and the vascular endothelium].
The recent discovery of endothelium-derived relaxation factor (EDRF) has altered the traditional classification of vasodilators used in angina pectoris and heart failure. If a vasodilator induces release of EDRF from the epithelium it is classified as endothelium-dependent, if not it is independent. Sodium nitroprusside and SIN-1 (active metabolite of molsidomine) are the main independent vasodilators since the endothelium relaxation factor appears to be principally a nitric oxide radical in these synthetic vasodilators. In contrast, calcium-channel blockers and a good number of endogenous chemical mediators (acetylcholine, bradykinin, serotonin, etc.) are endothelium-dependent. Furthermore, simple increase in blood flow through the large vessels can result in endothelium-dependent vasodilation (flow rate-dependence) the extent of which depends on the drug examined. The fact that the pharmacologic response of a vasodilator can be altered under certain pathologic conditions (atherosclerosis, hypertension, diabetes, etc.) further increases the importance of the role of the vascular endothelium in the action of vasodilators since endothelial modulation may then be completely diverted to secretion of endothelium-derived contracting factors (EDCFS).
Berdeaux
A
A
Département de Pharmacologie, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre.
D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D009569:Nitric Oxide / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000145:classification* / Q000494:pharmacology
D014665:Vasodilator Agents; D009569:Nitric Oxide
Vasodilatateurs et endothélium vasculaire.